UTMD · Utah Medical Products Inc
$70.77
-0.12 (-0.17%)
At close · Aug 27
Market Cap
$225.70M
Shares
3.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-07-23 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-04 | 2026-05-01 | |
| 8-K | 2026-04-23 | — | |
| DEF 14A | 2026-04-02 | — | |
| 10-K | 2026-03-27 | 2025-12-31 | |
| 8-K | 2026-01-29 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-23 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-07-24 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-05 | 2025-05-02 | |
| 8-K | 2025-04-29 | — | |
| DEF 14A | 2025-04-04 | — | |
| 10-K | 2025-03-26 | 2024-12-31 | |
| 8-K | 2025-01-28 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-05 | 2024-11-01 | |
| 8-K | 2024-10-29 | — | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-07-25 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-06 | 2024-05-03 | |
| 8-K | 2024-04-25 | — | |
| DEF 14A | 2024-04-10 | 2024-04-09 | |
| 10-K | 2024-03-26 | 2023-12-31 | |
| 8-K | 2024-01-30 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-10-31 | — | |
| 8-K | 2023-10-26 | — | |
| 10-Q | 2023-08-11 | 2023-06-30 | |
| 8-K | 2023-07-25 | — | |
| 8-K | 2023-05-08 | 2023-05-05 | |
| 10-Q | 2023-05-05 | 2023-03-31 | |
| 8-K | 2023-04-25 | — | |
| DEF 14A | 2023-04-04 | 2023-04-03 | |
| 10-K/A | 2023-03-28 | 2022-12-31 | |
| 10-K | 2023-03-27 | 2022-12-31 | |
| 8-K | 2023-01-31 | — | |
| 10-Q | 2022-11-10 | 2022-09-30 | |
| 8-K | 2022-11-01 | — | |
| 8-K | 2022-10-25 | — | |
| 10-Q | 2022-08-12 | 2022-06-30 | |
| 8-K | 2022-07-28 | 2022-07-26 | |
| 10-Q | 2022-05-11 | 2022-03-31 | |
| 8-K | 2022-05-09 | 2022-05-06 | |
| 8-K | 2022-04-27 | 2022-04-26 |
Showing 1–50 of 80 filings
Key facts
CIK
706698
CUSIP
917488108
13F (30d)
101 filings
99 filers
Visit website
Investor relations